166 results
10-K
2023 FY
EX-10.7
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
10-K
2023 FY
EX-10.6
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
8-K
EX-10.1
BTAX
Biostax Corp.
13 Sep 23
Departure of Directors or Certain Officers
5:16pm
8-K
EX-10.2
rpfkghj 3a
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.3
xqukk
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.1
oclvsewcj bvdf
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.2
aoiiimi7a1f1nv69f4v
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
7iu4 40t84
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
lsidgdjiyf
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-10.1
hdne9eh9qr 4j
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-10.1
gu5oju8h
7 Jul 22
Entry into a Material Definitive Agreement
5:27pm